Todd C Brady is a director of Evoke Pharma Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aldeyra Therapeutics, Inc.
12 Mar 24
144
Aldeyra Therapeutics, Inc.
11 Mar 24
4
Aldeyra Therapeutics, Inc.
11 Sep 23
4
Evoke Pharma Inc
11 May 23
4
F-star Therapeutics, Inc.
9 Mar 23
4
Aldeyra Therapeutics, Inc.
2 Mar 23
4
Aldeyra Therapeutics, Inc.
19 Jul 22
4
Aldeyra Therapeutics, Inc.
27 Jun 22
4
F-star Therapeutics, Inc.
22 Jun 22
4
Evoke Pharma Inc
28 Apr 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Mar 24 | ALDX Aldeyra Therapeutics | Common Stock | Sell | Dispose S | No | No | 3.05 | 85,324 | 260.24 k | 1,471,298 |
11 Mar 24 | ALDX Aldeyra Therapeutics | Common Stock | Sell | Dispose S | No | No | 3.2735 | 97,914 | 320.52 k | 1,556,622 |
9 Mar 24 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.62 | 1,081,201 | 3.91 mm | 1,081,201 |
7 Sep 23 | ALDX Aldeyra Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 7.22 | 73,807 | 532.89 k | 1,654,536 |
7 Sep 23 | ALDX Aldeyra Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.552 | 48,021 | 26.51 k | 1,728,343 |
7 Sep 23 | ALDX Aldeyra Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.552 | 32,953 | 18.19 k | 1,680,322 |
7 Sep 23 | ALDX Aldeyra Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.552 | 192,084 | 106.03 k | 1,647,369 |
7 Sep 23 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.552 | 48,021 | 26.51 k | 0 |
7 Sep 23 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.552 | 32,953 | 18.19 k | 0 |
7 Sep 23 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.552 | 192,084 | 106.03 k | 0 |